FDA Recalls: What's Left?

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Courtney Maxey-Jones, MD
Disclosure(s): Abiomed: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Atricure: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Doctorpedia: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Haemonetics: Advisory Board (Ongoing)

Jeffrey Javidfar, MD

Presentations

  1. Introduction and Interactive Baseline Audience Polling
     
  2. FDA Device Approval Process: From the Benchtop to the Shelf
    Joseph B. Zwischenberger, MD, FACS
    Disclosure(s): Avalon/Maquet: Royalties (Ongoing); WZ BioTech: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  3. What Devices Are OK? Discussion of Current MCS Device Recalls
    Leora T. Yarboro, MD
    Disclosure(s): Arthrex: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 22, 2024)
     
  4. Informed Consent—How to Discuss Recalls With Patients
    Anna L. Ciullo, MD
     
  5. But Will I Be Sued? Medicolegal Aspects of FDA Recalls
    Richard Lee, MD, JD, MBA
    Disclosure(s): Hochman and Lee,LL: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  6. Panel Discussion & Interactive Audience Survey
Activity summary
Available credit: 
  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Courtney Maxey-Jones, MD
Disclosure(s): Abiomed: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Atricure: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Doctorpedia: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Haemonetics: Advisory Board (Ongoing)

Jeffrey Javidfar, MD

Presentations

  1. Introduction and Interactive Baseline Audience Polling
     
  2. FDA Device Approval Process: From the Benchtop to the Shelf
    Joseph B. Zwischenberger, MD, FACS
    Disclosure(s): Avalon/Maquet: Royalties (Ongoing); WZ BioTech: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  3. What Devices Are OK? Discussion of Current MCS Device Recalls
    Leora T. Yarboro, MD
    Disclosure(s): Arthrex: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 22, 2024)
     
  4. Informed Consent—How to Discuss Recalls With Patients
    Anna L. Ciullo, MD
     
  5. But Will I Be Sued? Medicolegal Aspects of FDA Recalls
    Richard Lee, MD, JD, MBA
    Disclosure(s): Hochman and Lee,LL: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  6. Panel Discussion & Interactive Audience Survey